MENU
+Compare
ENZN
Stock ticker: OTC
AS OF
Jul 25 closing price
Price
$0.08
Change
-$0.01 (-11.11%)
Capitalization
5.62M

ENZN Enzon Pharmaceuticals, Inc. Forecast, Technical & Fundamental Analysis

Enzon Pharmaceuticals Inc is positioned as a public company acquisition vehicle, where the Company can become an acquisition platform and more fully utilize its net operating loss carryforwards and enhance stockholder value... Show more

Industry: #Biotechnology
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ENZN with price predictions
Jul 25, 2025

ENZN's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for ENZN moved out of overbought territory on July 01, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 instances where the indicator moved out of the overbought zone. In of the 23 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ENZN as a result. In of 129 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ENZN turned negative on July 11, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 66 similar instances when the indicator turned negative. In of the 66 cases the stock turned lower in the days that followed. This puts the odds of success at .

ENZN moved below its 50-day moving average on July 16, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ENZN crossed bearishly below the 50-day moving average on July 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENZN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ENZN broke above its upper Bollinger Band on June 27, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 74 cases where ENZN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where ENZN advanced for three days, in of 167 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.879) is normal, around the industry mean (18.019). P/E Ratio (96.098) is within average values for comparable stocks, (59.593). ENZN's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (217.391) is also within normal values, averaging (279.374).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ENZN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENZN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ENZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published Dividends

ENZN paid dividends on October 15, 2019

Enzon Pharmaceuticals, Inc. ENZN Stock Dividends
А dividend of $0.12 per share was paid with a record date of October 15, 2019, and an ex-dividend date of September 30, 2019. Read more...
A.I. Advisor
published General Information

General Information

a developer of innovative therapeutics for cancer patients

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
20 Commerce Drive
Phone
+1 732 980-4500
Employees
1
Web
http://www.enzon.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JBGS19.540.28
+1.45%
JBG SMITH Properties
HD375.342.25
+0.60%
Home Depot
BWB16.120.01
+0.06%
Bridgewater Bancshares
IONS42.15N/A
N/A
Ionis Pharmaceuticals
MOGO1.81-0.10
-5.24%
Mogo

ENZN and Stocks

Correlation & Price change

A.I.dvisor tells us that ENZN and CLDX have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENZN and CLDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENZN
1D Price
Change %
ENZN100%
-7.28%
CLDX - ENZN
8%
Poorly correlated
+0.56%
HALO - ENZN
2%
Poorly correlated
N/A
INCY - ENZN
2%
Poorly correlated
-0.41%
EXEL - ENZN
2%
Poorly correlated
+1.81%
ERNA - ENZN
-4%
Poorly correlated
-7.14%
More